(Press-News.org) CHICAGO, IL — People with significant hypothyroidism can experience impaired driving similar to those who are driving when intoxicated by alcohol, a new study finds. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
Hypothyroidism, insufficient thyroid hormone, is very common and has been known to cause impairment of many bodily functions, including brain function. Until now, studies have not sufficiently explored the extent of brain impairment and whether hypothyroid people are safe drivers, said the study's senior investigator, Kenneth Ain, MD, from the University of Kentucky and the Veterans Affairs Medical Center in Lexington, KY.
"We found that hypothyroid patients being tested on a driving simulator had a similar performance to that of drivers with a blood alcohol level above the legal limit in the U.S.," said co-author Charles Smith, MD, also of the University of Kentucky. "Physicians should warn their hypothyroid patients to avoid driving until they have been sufficiently treated with thyroid hormone."
In this study, thirty two patients with thyroid cancer, who were undergoing preparation for radioactive iodine scanning by stopping thyroid hormone, were evaluated with a battery of neurological and psychological tests, as well as testing on a driving simulator. They were studied when they were taking thyroid hormone, again when they were off of thyroid hormone, and then finally when they were back on thyroid hormone therapy.
Hypothyroid patients had depression and also showed declines in neurological function that resulted in increased automobile braking times; similar to the performance of drivers with a blood alcohol level of 0.082 g/100 mL. Taking thyroid hormone reversed all of these effects.
"Our results uncover a potential public and personal health hazard regarding impaired hypothyroid drivers," Ain said.
INFORMATION:
Funding for this study was provided by Genzyme, a Sanofi company.
Founded in 1916, the Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, the Endocrine Society's membership consists of over 17,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Washington, DC. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.
Hypothyroidism may lead to impaired driving
2014-06-23
ELSE PRESS RELEASES FROM THIS DATE:
High blood sugar causes brain changes that raise depression risk
2014-06-23
CHICAGO, IL — Researchers have found a possible biological reason why people with diabetes are prone to depression. A new study shows that high blood glucose (sugar) levels in patients with Type 1 diabetes increase the levels of a brain neurotransmitter associated with depression, and alter the connections between regions of the brain that control emotions. The results will be presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
"It was traditionally thought that patients with Type 1 or ...
Soy supplements appear to be safe, beneficial in diabetic men
2014-06-23
CHICAGO, IL—Soy protein supplements, which contain natural estrogens, do not reduce testosterone levels in men with Type 2 diabetes who already have borderline-low testosterone, according to a new study. The results were presented Saturday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
"Because soy contains phytoestrogens that are similar to the female hormone estrogen, it was not known whether consumption of soy could reduce testosterone levels in men with Type 2 diabetes, who are at increased risk ...
Most people with type 1 diabetes do not use diabetes devices to get long-term data
2014-06-23
CHICAGO, IL—Almost 70 percent of adults with Type 1 diabetes never use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses—information that likely would help them manage their disease better. These new survey results, which were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago, also show that only 12 percent of patients regularly review their past glucose and insulin pump data at home.
"This research ...
BPA exposure during fetal development raises risk of precancerous prostate lesions
2014-06-23
CHICAGO, IL — A new study has found for the first time that the endocrine-disrupting chemical bisphenol A (BPA) reprograms the developing prostate, making the gland more susceptible to precancerous lesions and other diseases later in a man's life. The results will be reported Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
"By using two novel models of human prostate development involving embryonic stem cells, this study is the first to show that low doses of BPA can actually reprogram human ...
Denosumab treatment for postmenopausal osteoporosis increases bone density
2014-06-23
CHICAGO, IL — Postmenopausal women with osteoporosis who take denosumab long-term have increased bone density, sustained low rate of fractures, and a favorable benefit/risk profile, a new multinational study finds. The results were presented Sunday, June 22, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago.
"This study provides reassurance to physicians and their patients that long-term treatment with denosumab for at least 8 years leads to significant increases in bone density and is safe for appropriately ...
Empagliflozin lowers high blood pressure and blood sugar in diabetics
2014-06-23
CHICAGO, IL — An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
This improvement in blood pressure reportedly was accompanied by a reduction in blood glucose (sugar) levels after 12 weeks of treatment with the drug, which is under development by Germany-based Boehringer ...
Nutritional sports supplements sold in Australia test positive for banned androgens
2014-06-23
CHICAGO, IL — Some nutritional sports supplements marketed to athletes -- claiming to help them build lean muscle, reduce body fat and enhance endurance -- are secretly fortified with androgens, which are banned from use in sports, a new study from Australia finds. The results will be presented in a poster Sunday, June 22, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago.
"The point is that 'you can't judge a book by its cover.' The nutritional supplement label may not disclose all ingredients, and ...
University scientists unraveling nature of Higgs boson
2014-06-23
MANHATTAN, Kansas — New physics research involving Kansas State University faculty members has helped shed light on how our universe works.
A recently published study in the journal Nature Physics reports scientists have found evidence that the Higgs boson — a fundamental particle proposed in 1964 and discovered in 2012 — is the long sought-after particle responsible for giving mass to elementary particles.
"In nature, there are two types of particles: fermions and bosons," said Ketino "Keti" Kaadze, a research associate at Fermilab who in August is joining the faculty ...
Low testosterone raises risk of age-related functional disability
2014-06-23
CHICAGO, IL — Elderly men with low levels of testosterone or other sex hormones have twice the likelihood of having declining physical function over two years' time compared with their peers who have the highest hormone levels, a new study from Australia finds. The results were presented Saturday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
"We also found that increasing muscle weakness—possibly due to decreasing testosterone concentration in the blood—could explain most of this relationship," ...
Gestational diabetes is associated with declining cognitive function
2014-06-23
CHICAGO, IL — Women who develop diabetes during pregnancy, called gestational diabetes, perform worse on cognitive function tests than do women with a normal pregnancy, according to a new study from Turkey. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
Type 2 diabetes has been linked to accelerated cognitive, or brain-related, decline and an increased risk of dementia in elderly individuals. However, exactly when the memory problems can begin during diabetes is ...